Current Price
Target Price
VectivBio Holding AG, a clinical-stage biopharmaceutical company, focuses on the discovery, development and commercialization of treatments for rare conditions. The company is headquartered in Basel, Switzerland.
e.g. Promoter holding
Loading chart...
Analyst consensus EPS and Revenue forecasts.
| Metric (B) | FY 2021 | FY 2021 | FY 2021 | FY 2022 | FY 2022 |
|---|---|---|---|---|---|
| $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| 0 | 0 | 0 | 0.03 | 0.03 | |
| +100.0% | +100.0% | +100.0% | +100.0% | +100.0% |
No peer comparison data available for this company.
Consolidated Figures in Millions / View Standalone.
| Quarter (M) | Mar 21 | Jun 21 | Sep 21 | Dec 21 | Mar 22 | Jun 22 | Dec 22 | Mar 23 |
|---|---|---|---|---|---|---|---|---|
Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.68 |
COGS | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Gross Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.68 |
Gross Profit % | - | - | - | - | - | - | - | 100% |
| -21.73 | -21.73 | -21.73 | -21.73 | -21.73 | 0 | 21.5 | -40.04 | |
EBIT | -21.73 | -21.73 | -21.73 | -21.73 | -21.73 | 0 | -21.68 | -28.55 |
OPM % | - | - | - | - | - | - | - | -4223.85% |
Non-Operating Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.03 |
PBT | -21.74 | -21.74 | -21.74 | -21.74 | -21.74 | 0 | -21.74 | -28.53 |
Income Tax | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | 0.02 | -0.05 |
Tax Rate % | -0.07% | -0.07% | -0.07% | -0.07% | -0.07% | - | -0.07% | 0.17% |
Net Income | -21.75 | -21.75 | -21.75 | -21.75 | -21.75 | 0 | -21.75 | -28.48 |
NPM % | - | - | - | - | - | - | - | -4212.76% |
Consolidated Figures in Millions / View Standalone.
| Period (M) | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 |
|---|---|---|---|---|
Revenue | 0 | 0 | 0 | 27.34 |
COGS | 0 | 0 | 0 | 0 |
Gross Profit | 0 | 0 | 0 | 27.34 |
Gross Profit % | - | - | - | 100% |
| 24.32 | 57.26 | 86.72 | 107.86 | |
EBIT | -24.32 | -57.26 | -86.72 | -80.52 |
OPM % | - | - | - | -294.52% |
Non-Operating Income | 0.83 | -2.68 | -0.23 | -13.1 |
PBT | -23.48 | -59.94 | -86.94 | -93.63 |
Income Tax | 0.05 | 0.55 | 0.06 | 0.11 |
Tax Rate % | -0.21% | -0.92% | -0.07% | -0.11% |
Net Income | -23.53 | -60.5 | -87.01 | -93.73 |
NPM % | - | - | - | -342.84% |
Consolidated Figures in Millions / View Standalone.
| Period (M) | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 |
|---|---|---|---|---|---|
| 2.13 | 19.81 | 40.17 | 102.71 | 221.42 | |
| 0.01 | 0.08 | 0.07 | 0.07 | 0.07 | |
| 0 | 0.44 | 0.29 | 0.34 | 0 | |
| 0.51 | 1.36 | 7.38 | 7.37 | 4.79 | |
| 21.17 | 22.21 | 22.66 | 26.05 | 26.33 | |
Total Assets | 23.82 | 43.9 | 70.56 | 136.53 | 252.6 |
| 0 | 0.49 | 1.37 | 1.9 | 3.5 | |
| 11.24 | 8.77 | 30.87 | 114.1 | 209.87 | |
| 0 | 19.98 | 0.12 | 0.29 | 10.46 | |
| 0.66 | 9.3 | 28.22 | 16.7 | 20.28 | |
| 11.92 | 5.35 | 9.99 | 3.54 | 8.49 | |
Total Liabilities | 23.82 | 43.9 | 70.56 | 136.53 | 252.6 |
Consolidated Figures in Millions / View Standalone.
| Period (M) | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 |
|---|---|---|---|---|
| -14.9 | -38.21 | -72.14 | -56.26 | |
| -0.04 | -0.07 | -6.67 | -0.07 | |
| 32.81 | 56.59 | 141.33 | 175.06 | |
Net CFNet Cash Flow | 17.87 | 18.31 | 62.52 | 118.72 |
FCFFree Cash Flow | -14.95 | -38.3 | -72.2 | -56.33 |
Financial ratios and valuation metrics by fiscal year.
| Period | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 |
|---|---|---|---|---|---|
| - | -229.5% | -291.6% | -117.4% | -56.9% | |
| - | 2.16 | 0.00 | 0.00 | 0.05 | |
| 4.04 | 0.65 | 1.37 | 6.41 | 9.14 | |
| - | 0.00 | 0.00 | 0.00 | 0.14 | |
Cash Conversion | - | 0.63 | 0.63 | 0.83 | 0.60 |
Payout Ratio | - | - | - | - | - |
| - | - | - | - | - | |
| - | - | - | - | - | |
| - | - | - | - | - | |
| - | 3.00 | 3.00 | 4.00 | 4.00 | |
| - | - | - | - | - | |
| - | 0.00 | 50.00 | 50.00 | 66.67 | |
| - | - | - | - | -3.4% |
Note: These ratios and scores are calculated using publicly available financial data and may differ from other sources. Users are advised to verify calculations independently using SEC filings or other official sources before making investment decisions.
Who owns VectivBio Holding AG, from SEC filings
Shares sold short · updated twice a month
| Settlement date | Short shares | Change | Days to cover | Relative size |
|---|---|---|---|---|
| 30 Jun 2023 | 168,463 | +117.1% | 1.00 | |
| 15 Jun 2023 | 77,601 | -21.3% | 1.00 | |
| 31 May 2023 | 98,596 | -83.0% | 1.00 | |
| 15 May 2023 | 580,296 | +123.4% | 13.52 | |
| 28 Apr 2023 | 259,739 | +113.6% | 3.23 | |
| 14 Apr 2023 | 121,604 | -8.2% | 1.84 | |
| 31 Mar 2023 | 132,441 | +25.7% | 3.77 | |
| 15 Mar 2023 | 105,390 | +86.1% | 6.83 | |
| 28 Feb 2023 | 56,645 | -59.7% | 8.18 | |
| 15 Feb 2023 | 140,536 | +15.9% | 6.80 | |
| 31 Jan 2023 | 121,269 | +342.3% | 5.21 | |
| 13 Jan 2023 | 27,417 | +62.5% | 1.00 | |
| 30 Dec 2022 | 16,867 | -9.0% | 4.43 | |
| 15 Dec 2022 | 18,539 | +12.0% | 2.66 | |
| 30 Nov 2022 | 16,549 | -26.6% | 3.82 | |
| 15 Nov 2022 | 22,554 | +41.5% | 2.09 | |
| 31 Oct 2022 | 15,940 | -35.6% | 1.12 | |
| 14 Oct 2022 | 24,742 | +708.6% | 1.00 | |
| 30 Sep 2022 | 3,060 | +61.3% | 1.00 | |
| 15 Sep 2022 | 1,897 | +14.3% | 1.00 | |
| 31 Aug 2022 | 1,660 | -55.7% | 1.00 | |
| 15 Aug 2022 | 3,743 | +152.4% | 1.00 | |
| 29 Jul 2022 | 1,483 | -63.6% | 1.00 | |
| 15 Jul 2022 | 4,069 | +5.2% | 1.00 |
FINRA consolidated short interest, reported twice a month for every US listing.
VectivBio Holding AG's SEC filings and earnings call transcripts
What recent news says about VectivBio Holding AG, scored for sentiment.